Melatonin and mammary cancer: A short review

Endocrine-Related Cancer

Volumn 10, Issue 2, 2003, Pages 153-159

  Sanchez Barcelo E J ^a   Cos, S ^a   Fernandez R ^a   Mediavilla, M D ^a  

^a UNIVERSITY OF CANTABRIA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIESTROGEN; BETA1 INTEGRIN; ESTRADIOL; ESTROGEN; ESTROGEN RECEPTOR; MELATONIN; UVOMORULIN;

BREAST CANCER; BREAST CARCINOGENESIS; CELL ADHESION; CELL PROLIFERATION; CLINICAL PATHWAY; CONFERENCE PAPER; DISEASE MODEL; ESTROGEN ACTIVITY; FEMALE; HORMONAL REGULATION; HORMONE ACTION; HORMONE RELEASE; HORMONE RESPONSE; HUMAN; IN VITRO STUDY; IN VIVO STUDY; LATENT PERIOD; NONHUMAN; PINEAL BODY; TRANSCRIPTION INITIATION; TUMOR GROWTH; VISUAL IMPAIRMENT;

ANIMALS; ANTINEOPLASTIC AGENTS; BREAST NEOPLASMS; FEMALE; HUMANS; MELATONIN; MICE; NEOPLASMS, HORMONE-DEPENDENT; TUMOR CELLS, CULTURED;

EID: 0037937566     PISSN: 13510088     EISSN: None     Source Type: Journal    
DOI: 10.1677/erc.0.0100153     Document Type: Conference Paper

References (45)

1. Arónica SM, Kraus WL & Katzenellenbogen BS 1994 Estrogen action via the cAMP signalling pathway: stimulation of adenylate cyclase and cAMP-regulated gene transcription. PNAS 91 8517-8521.
2. Benitez-King G, Huerto-Delgadillo L & Anton-Tay F 1993 Binding at 3H-melatonin to calmodulin. Life Sciences 53 201-207.
3. 2+/calmodulin-dependent kinase II activity by melatonin. Biochimica et Biophysica Acta 1290 191-196.
4. Bouhoute A & Leclercq G 1995 Modulation of estradiol and DNA binding to estrogen receptor upon association with calmodulin. Biochemical and Biophysical Research Communications 208 748-755.
5. Brainard GC, Rollag MD & Hanifin JP 1997 Photic regulation of melatonin in humans: ocular and neural signal transduction. Journal of Biological Rhythms 12 537-546.
6. Brainard GC, Kavet R & Kheifets LI 1999 The relationship between electromagnetic field and light exposures to melatonin and breast cancer risk: a review of the relevant literature. Journal of Pineal Research 26 65-100.
7. Brzezinski A 1997 Melatonin in humans. New England Journal of Medicine 336 186-195.
8. Caplan LS, Schoenfeld ER, O'Leary ES & Leske MC 2000 Breast cancer and electromagnetic fields - a review. Annals of Epidemiology 10 31-44.
9. 2+-calmodulin. Molecular Endocrinology 2 167-174.
10. Cohen M, Lippman M & Chabner B 1978 Role of the pineal gland in the aetiology and treatment of breast cancer. Lancet 2 814-816.
11. Coleman MP & Reiter RJ 1992 Breast cancer, blindness and melatonin. European Journal of Cancer 28 501-503.
12. Cos S & Sánchez-Barceló EJ 1994 Differences between pulsatile or continuous exposure to melatonin on MCF-7 human breast cancer cell proliferation. Cancer Letters 85 105-109.
13. Cos S & Fernandez R 2000 Melatonin effects on intercellular junctional communication in MCF-7 human breast cancer cells. Journal of Pineal Research 29 166-171.
14. Cos S & Sánchez-Barceló EJ 2000a Melatonin and mammary pathological growth. Frontiers in Neuroendocrinology 21 133-170.
15. Cos S & Sánchez-Barceló EJ 2000b Melatonin - experimental basis for a possible application in breast cancer prevention and treatment. Histology and Histopathology 15 637-647.
16. Cos S & Sánchez-Barceló EJ 2000c In vitro effects of melatonin in tumor cells. In The Pineal Gland and Cancer: Neuroimmunoendocrine Interactions in Malignancy, pp 221-239. Eds C Bartch, H Bartch, DE Blask, DP Cardinali, WJM Hrushesky & D Mecke. Berlin, Germany: Springer-Verlag.
17. Cos S, Blask DE, Lemus-Wilson A & Hill SM 1991 Effects of melatonin on the cell cycle kinetics and 'estrogen-rescue' of MCF-7 human breast cancer cells in culture. Journal of Pineal Research 10 36-43.
18. Cos S, Recio J & Sánchez-Barceló EJ 1996 Modulation of the length of the cell cycle time of MCF-7 human breast cancer cells by melatonin. Life Sciences 58 811-816.
19. Cos S, Fernández R, Güézmes A & Sánchez-Barceló EJ 1998 Influence of melatonin on invasive and metastatic properties of MCF-7 human breast cancer cells. Cancer Research 58 4383-4390.
20. Cos S, Mediavilla MD, Fernández R, González-Lamuño D & Sánchez-Barceló EJ 2002 Does melatonin induce apoptosis in MCF-7 human breast cancer cells in vitro? Journal of Pineal Research 32 90-96.
21. Dai J, Inscho EW, Yuan L & Hill SM 2002 Modulation of intracellular calcium and calmodulin by melatonin in MCF-7 human breast cancer cells. Journal of Pineal Research 32 112-119.
22. Feychting M, Österlund B & Ahlbom A 1998 Reduced cancer incidence among the blind. Epidemiology 9 490-494.
23. García-Pedrero JM, Martínez MA, Del Rio B, Martínez-Campa C, Muramatsu M, Lazo PS & Ramos S 2002 Calmodulin is a selective modulator of estrogen receptors. Molecular Endocrinology 16 947-960.
24. García-Rato A, García-Pedrero JM, Martínez MA, Del Rio B, Lazo PS & Ramos S 1999 Melatonin blocks the activation of estrogen receptor for DNA binding. FASEB Journal 13 857-868.
25. Jones MP, Melan MA & Witt-Enderby PA 2000 Melatonin decreases cell proliferation and transformation in a melatonin receptor-dependent manner. Cancer Letters 151 133-143.
26. Kheifets LI & Matkin CC 1999 Industrialization, electromagnetic fields, and breast cancer risk. Environmental Health Perspectives 107 145-154.
27. Kiefer T, Ram PT, Yuan L & Hill SM 2002 Melatonin inhibits estrogen receptor transactivation and cAMP levels in breast cancer cells. Breast Cancer Research and Treatment 71 37-45.
28. Kliukiene J, Tynes T & Andersen A 2001 Risk of breast cancer among Norwegian women with visual impairment. British Journal of Cancer 84 397-399.
29. Lawson NO, Wee BE, Blask DE, Castles CG, Spriggs LL & Hill SM 1992 Melatonin decreases estrogen receptor expression in the medial preoptic area of inbred (LSH/SsLak) golden hamsters. Biology of Reproduction 47 1082-1090.
30. Maestroni GJM 1993 The immunoneuroendocrine role of melatonin. Journal of Pineal Research 14 1-10.
31. Mediavilla MD, Güézmes A, Ramos S, Kothari L, Garijo F & Sánchez-Barceló EJ 1997 Effects of melatonin on mammary gland lesions in transgenic mice overexpressing N-ras proto-oncogene. Journal of Pineal Research 22 86-94.
32. Mediavilla MD, Cos S & Sánchez-Barceló EJ 1999 Melatonin increases p53 and p21WAF1 expression in MCF-7 human breast cancer cells in vitro. Life Sciences 65 415-420.
33. Molis TM, Spriggs LL & Hill SM 1994 Modulation of estrogen receptor mRNA expression by melatonin in MCF-7 human breast cancer cells. Molecular Endocrinology 8 1681-1690.
34. Molis TM, Spriggs LL, Jupiter Y & Hill SM 1995 Melatonin modulation of estrogen-regulated proteins, growth factors, and proto-oncogenes in human breast cancer. Journal of Pineal Research 18 93-103.
35. Musgrove EA, Wakeling AE & Sutherland RL 1989 Points of action of estrogen antagonist within the MCF-7 human breast cancer cell cycle. Cancer Research 49 2398-2404.
36. Ram PT, Kiefer T, Silverman M, Song Y, Brown GM & Hill SM 1998 Estrogen receptor transactivation in MCF-7 breast cancer cells by melatonin and growth factors. Molecular and Cellular Endocrinology 141 53-64.
37. Ram PT, Dai J, Yuan L, Dong C, Kiefer TL, Lai L & Hill SM 2002 Involvement of the mt1 melatonin receptor in human breast cancer. Cancer Letters 179 141-150.
38. Rao GN, Ney E & Herbert RA 2000 Effect of melatonin and linoleic acid on mammary cancer in transgenic mice with c-neu breast cancer oncogene. Breast Cancer Research and Treatment 64 287-296.
39. Reiter RJ 1980 The pineal gland and its hormones in the control of reproduction in mammals. Endocrine Reviews 1 109-131.
40. Reiter RJ, Melchiorri D, Sewerynek E, Poeggeler B, Barlow-Walden L, Chuang J, Ortiz GC & Acuña-Castroviejo D 1995 A review of the evidence supporting melatonin's role as an antioxidant. Journal of Pineal Research 18 1-11.
41. Subramanian A & Kothari L 1991 Melatonin, a suppressor of spontaneous murine mammary tumors. Journal of Pineal Research 10 136-140.
42. Tamarkin L, Danforth DN, Lichter A, DeMoss E, Cohen M, Chabner B & Lippman M 1982 Decreased nocturnal plasma melatonin peak in patients with estrogen receptor positive breast cancer. Science 216 1003-1005.
43. Verkasalo PK, Pukkala E, Stevens RG, Ojamo M & Rudanko SL 1999 Inverse association between breast cancer incidence and degree of visual impairment in Finland. British Journal of Cancer 80 1459-1460.
44. Wilson ST, Blask DE & Lemus-Wilson AM 1992 Melatonin augments the sensitivity of MCF-7 human breast cancer cells to tamoxifen in vitro. Journal of Clinical Endocrinology and Metabolism 75 669-670.
45. Yuan L, Collins AR, Dai J, Dubocovich ML & Hill SM 2002 MT1 melatonin receptor overexpression enhances the growth suppressive effects of melatonin in human breast cancer cells. Molecular and Cellular Endocrinology 192 147-156.